Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Expanding the Vision for Fitzsimons Innovation Community
News | Jun 10, 2024

Expanding the Vision for Fitzsimons Innovation Community

Fitzsimons Innovation Community is expanding life sciences innovation in the region with an updated mater plan for the 184-acre innovation campus to the north of the world-renowned University of Colorado Anschutz Medical Center. The innovation community is currently home to more than 80 visionary companies taking their research to the next level to cure disease, save lives and improve care. Centrally located within 20 minutes of Denver International Airport, downtown Denver and the Denver Tech Center, Fitzsimons Innovation Community is custom-built for discovery with state-of-the-art facilities and flex spaces, opportunities for strategic partnerships and collaboration, a broad range of community amenities and the best of the Colorado lifestyle.

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain
News | May 30, 2024

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain

Focusing on non-addictive treatments for chronic pain and addiction, Lohocla Research Corporation gets the go-ahead for first-in-human trials of their first-in-class therapeutic for chronic pain syndromes.

Lohocla Research Embarks Upon Phase 1 Human Trials
News | May 24, 2024

Lohocla Research Embarks Upon Phase 1 Human Trials

Exciting news from Lohocla Research Corporation! Lohocla, one of our member companies, has just announced the start of Phase 1 clinical trials for Kindolor, a pioneering non-addictive small molecule aimed at treating and preventing chronic pain disorders. This marks a crucial milestone in the journey toward a groundbreaking new treatment.

Colorado: Fueling the Future of Life Sciences
News | May 22, 2024

Colorado: Fueling the Future of Life Sciences

A group of 22 partners representing Colorado’s life sciences ecosystem have banded together to fund a new national economic development campaign to bolster Colorado into “America’s epicenter for life sciences innovation.”

CREJ Features Insights from April Giles on Choosing an Innovation Community
News | Apr 16, 2024

CREJ Features Insights from April Giles on Choosing an Innovation Community

For health care and life sciences companies beginning the search for a new facility to call home, innovation communities are often sought-after destinations.

GelSana Awarded an AFWERX Phase II SBIR Contract to Develop Novel Polymers for Enhanced Wound Healing in Combat-Related Burn Injuries
News | Apr 11, 2024

GelSana Awarded an AFWERX Phase II SBIR Contract to Develop Novel Polymers for Enhanced Wound Healing in Combat-Related Burn Injuries

GelSana, a Fitzsimons Innovation Community member company, will focus their efforts on the development of novel wound dressing polymers for the care of combat-related burn injuries.

EnteroTrack selected for prestigious cancer accelerator program
News | Apr 08, 2024

EnteroTrack selected for prestigious cancer accelerator program

Announced on the stage at ViVE 2024, EntroTrack was selected for the inaugural cohort from a robust list of startup applicants aiming to reduce the burden of cancer for all people.

CNBC Highlights Colorado’s Role as Life Sciences Leader
News | Apr 08, 2024

CNBC Highlights Colorado’s Role as Life Sciences Leader

Record levels of funding propel Denver-Boulder to the top of the life sciences market.

Gates Institute Releases Annual Report Highlighting Cell and Gene Therapy Innovation
News | Apr 05, 2024

Gates Institute Releases Annual Report Highlighting Cell and Gene Therapy Innovation

Gates Institute is a World-class translational research institute with biomanufacturing capabilities. Based at the University of Colorado Anschutz Medical Campus, they are part of a rich biomedical ecosystem, enabling the development of life-saving treatments for a host of diseases at unmatched speed and scope.

Aurora’s Platinum Triangle Area Experiences Dramatic Growth
News | Apr 01, 2024

Aurora’s Platinum Triangle Area Experiences Dramatic Growth

As Colorado’s third largest and most diverse city, Aurora has always held a prominent position in terms of employment, commercial development, and residential prospects. The employment clusters are growing more than ever, especially with the blossoming development of the Platinum Triangle area – an impressive 21,000-acre vicinity located south of Denver International Airport (DEN).

Ceria Therapeutics Welcomes Garrett Vygantas, M.D., to Board of Directors
News | Mar 22, 2024

Ceria Therapeutics Welcomes Garrett Vygantas, M.D., to Board of Directors

Ceria Therapeutics welcomes Garrett Vygantas, M.D., to their Board of Directors! Their new board member brings a strong record of leadership and success as an investor and company developer in the biopharmaceutical sector.

Spinelli's Team Opening Third Market at Fitzsimons Innovation Community
News | Mar 18, 2024

Spinelli's Team Opening Third Market at Fitzsimons Innovation Community

"Grocery stores like this are community builders. ... You still make the same connection you did in the restaurant, but it's so much more wholesome," Jones told Westword just before the Congress Park market opened. "[Jake and Cecelia] are just so passionate about taking existing spaces and creating that community around it," says Stephanie Joslin, director of communications for AIR Communities, which owns 21 Fitzsimons and the Fremont, two apartment communities located at the heart of the Anschutz Medical Campus.